Kent W Mouw

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Radical Prostatectomy

Prostate Cancer

Ejection Fraction

Top Venues

Science advances

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Uttam Satyal, Henkel Valentine, David R Liu, Michael J Slifker, Costas D Lallas, Edouard J Trabulsi, Laura Bukavina, Lauren Szeto, Jean H Hoffman-Censits, Kent W Mouw, Bishoy Morris Faltas, Petros D Grivas, Ilsiya Ibragimova, Sima P Porten, Eliezer Van Allen, Daniel M Geynisman, Daniel C Parker, John P O'Neill, Johnathan A Drevik, Sarah S Christianson, Serge Ginzburg, Andres F Correa, Robert G Uzzo, Eric A Ross, Matthew R Zibelman, Pooja Ghatalia, Elizabeth R Plimack, Alexander Kutikov, Philip H Abbosh
Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates. JCO precision oncology 8 (2024)
Justin H Hwang, Xiaolei Shi, Andrew Elliott, Taylor E Arnoff, Julie E McGrath, Joanne Xiu, Phillip Walker, Hannah E Bergom, Abderrahman Day, Shihab Ahmed, Sydney Tape, Allison Makovec, Atef Ali, Rami M Shaker, Eamon Toye, Rachel Passow, John R Lozada, Jinhua Wang, Emil Lou, Kent W Mouw, Benedito Arruda Carneiro, Elisabeth I Heath, Rana R McKay, Wolfgang Michael Korn, Chadi Nabhan, Charles J Ryan, Emmanuel S Antonarakis
Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Yuzhen Zhou, Judit Börcsök, Elio Adib, Sophia C Kamran, Alexander J Neil, Konrad Stawiski, Dory Freeman, Dag Rune Stormoen, Zsófia M Sztupinszki, Amruta Samant, Amin H Nassar, Raie T Bekele, Timothy Hanlon, Henkel Valentine, Ilana Epstein, Bijaya Sharma, Kristen Felt, Philip Abbosh, Chin-Lee Wu, Jason Alexander Efstathiou, David T Miyamoto, William Anderson, Zoltan Szallasi, Kent W Mouw
ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer. Science advances 9 (47) (2023)
Sophia C Kamran, Yuzhen Zhou, Keisuke Otani, Michael R Drumm, Yukako Otani, Shu-Lin Wu, Chin-Lee Wu, Adam S Feldman, Matthew Wszolek, Richard J Lee, Philip J Saylor, Jochen K Lennerz, Eliezer Van Allen, Henning Willers, Theodore S Hong, Yang Liu, Elai Davicioni, Ewan A Gibb, William U Shipley, Kent W Mouw, Jason Alexander Efstathiou, David T Miyamoto
Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Kasia M Dillon, Raie T Bekele, Zsofia Sztupinszki, Timothy Hanlon, Shahrzad Rafiei, Zoltan Szallasi, Atish D Choudhury, Kent W Mouw
PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer. NPJ precision oncology 6 (1) (2022)
Guru P Sonpavde, Kent W Mouw, Matthew Mossanen
Therapy for Muscle-Invasive Urothelial Carcinoma: Controversies and Dilemmas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (12) (2022)
Hae Lin Cho, Vedang Murthy, Kent W Mouw, Anthony V D'Amico, Paul L Nguyen, Jonathan E Leeman, Edward Christopher Dee
Second malignancy probabilities in patients with prostate cancer treated with whole pelvis radiation therapy versus prostate only radiation therapy. The Prostate 82 (11) (2022)
Chenkui Miao, Takuya Tsujino, Tomoaki Takai, Fu Gui, Takeshi Tsutsumi, Zsófia M Sztupinszki, Zengjun Wang, Haruhito Azuma, Zoltan Szallasi, Kent W Mouw, Lee Zou, Adam S Kibel, Li Jia
RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer. Science advances 8 (7) (2022)